Pump Mails at Pharmacyte Biotech Inc (OTCMKTS:PMCB) are a routine, however, in the latest case on Friday, the compensation paid out to the several promoters had shrunk significantly. The paying party was new, which resulted in lower compensations. In the last trading session, PharmaCyte closed another 1.4% down.
The pump emails
A third party known as Cream Consulting was handing out compensation to several promoter outfits to advertise Pharmacyte. Last Tuesday, there were as much as seven touts, each revealing $25 thousand in compensation. It implies that Cream Consulting was trying to increase their pumping game. As a result, now a new party will be handing out compensation to advertise Pharmacyte Biotech Inc (OTCMKTS:PMCB)’s stock. The two new promotional emails sent out by Stock Roach and Stock Hideout was planned by Action Media Holdings. This time the two touts were paid just $4 thousand for their promotional efforts.
The adverse impact
Pharmacyte Biotech Inc (OTCMKTS:PMCB) has received more than 40 email pumps in 2015. It is alarming as the non-stop paid touting is one of the main reasons behind a 30% decline in the company’s stock in 2015. The prolonged pumping is considered to have a negative impact on stock prices. If analyzed, the pumps have done Pharmacyte more harm than good.
Pharmacyte Biotech Inc (OTCMKTS:PMCB) has a team of experienced medical professional; still it has failed to excel in the industry. IN its latest report of October 2014, it made no revenues. It reported quarterly net loss of $4 million. The free cash was $1.1 million, and liabilities stood at $276 thousand. The experts believe that if the business is left alone without any support from promoters, the company will find its way on its accomplishments and merits. As of now, the ongoing paid touting had not resulted in any benefits, and, therefore, it would be a wise step to take a break from email pumps.